This paper is in the following e-collection/theme issue:

Digital Health Reviews (1331) Digital Biomarkers and Digital Phenotyping (198) Ubiquitous Health (uHealth) (125) Dementia and Cognitive Decline (505)

Published on in Vol 21, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12785, first published .
Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Authors of this article:

Antoine Piau1, 2 Author Orcid Image ;   Katherine Wild2 Author Orcid Image ;   Nora Mattek2 Author Orcid Image ;   Jeffrey Kaye2 Author Orcid Image
Article Authors Cited by (141) Tweetations (8) Metrics

Antoine Piau   1, 2 , MD, PhD ;   Katherine Wild   2 , PhD ;   Nora Mattek   2 , MPH ;   Jeffrey Kaye   2 , MD

1 Gerontopole, University Hospital of Toulouse, UPS, Toulouse, France

2 Oregon Center for Aging and Technology (ORCATECH), Oregon Health and Science University, Portland, OR, United States

Corresponding Author:

  • Antoine Piau, MD, PhD
  • Oregon Center for Aging and Technology (ORCATECH)
  • Oregon Health and Science University
  • 3181 SW Sam Jackson Park Rd
  • Portland, OR, 97239
  • United States
  • Phone: 1 971-230-8664
  • Email: antoinepiau@hotmail.com